237 related articles for article (PubMed ID: 10975392)
41. Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy.
Avilés A; Neri N; Fernández R; Calva A; Huerta-Guzmán J; Nambo MJ
Med Oncol; 2003; 20(1):13-7. PubMed ID: 12665679
[TBL] [Abstract][Full Text] [Related]
42. L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma.
Yong W; Zheng W; Zhang Y; Zhu J; Wei Y; Zhu D; Li J
Int J Hematol; 2003 Aug; 78(2):163-7. PubMed ID: 12953813
[TBL] [Abstract][Full Text] [Related]
43. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ
Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382
[TBL] [Abstract][Full Text] [Related]
44. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
Feng YF; Wu QL; Zong YS
Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
[TBL] [Abstract][Full Text] [Related]
45. NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey.
Pagano L; Gallamini A; Trapè G; Fianchi L; Mattei D; Todeschini G; Spadea A; Cinieri S; Iannitto E; Martelli M; Nosari A; Bona ED; Tosti ME; Petti MC; Falcucci P; Montanaro M; Pulsoni A; Larocca LM; Leone G;
Ann Oncol; 2006 May; 17(5):794-800. PubMed ID: 16497823
[TBL] [Abstract][Full Text] [Related]
46. Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.
Tababi S; Kharrat S; Sellami M; Mamy J; Zainine R; Beltaief N; Sahtout S; Besbes G
Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Jun; 129(3):141-7. PubMed ID: 22321911
[TBL] [Abstract][Full Text] [Related]
47. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients.
Akiyama T; Okino T; Konishi H; Wani Y; Notohara K; Tsukayama C; Tsunoda T; Tasaka T; Masaki Y; Sugihara T; Sadahira Y
Pathol Int; 2008 Oct; 58(10):626-34. PubMed ID: 18801082
[TBL] [Abstract][Full Text] [Related]
48. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
49. Nasal T cell lymphoma: a rare entity.
Kazi M; Ikram M; Junaid M
J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S50-1. PubMed ID: 24718007
[TBL] [Abstract][Full Text] [Related]
50. Adoptive transfer of Epstein-Barr virus-specific cytotoxic T-lymphocytes for the treatment of angiocentric lymphomas.
Cho HI; Hong YS; Lee MA; Kim EK; Yoon SH; Kim CC; Kim TG
Int J Hematol; 2006 Jan; 83(1):66-73. PubMed ID: 16443556
[TBL] [Abstract][Full Text] [Related]
51. [Nasal and pharyngeal non-Hodgkin lymphomas and their relationship with Epstein-Barr virus: a report of 158 cases].
He YJ; Jia XS; Hasui K; Wang EH; He AG
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):94-7. PubMed ID: 17493382
[TBL] [Abstract][Full Text] [Related]
52. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
Tse E; Kwong YL
Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
[TBL] [Abstract][Full Text] [Related]
53. CD56+ NK lymphomas: clinicopathological features and prognosis.
Kwong YL; Chan AC; Liang R; Chiang AK; Chim CS; Chan TK; Todd D; Ho FC
Br J Haematol; 1997 Jun; 97(4):821-9. PubMed ID: 9217183
[TBL] [Abstract][Full Text] [Related]
54. Treatment outcome and prognostic factors for primary nasal lymphoma.
Liang R; Todd D; Chan TK; Chiu E; Lie A; Kwong YL; Choy D; Ho FC
J Clin Oncol; 1995 Mar; 13(3):666-70. PubMed ID: 7884427
[TBL] [Abstract][Full Text] [Related]
55. CMED in the treatment of nasal natural killer cell lymphoma with distant metastases.
Avilés A; Cleto S; Castañeda C; Nambo MJ
Hematology; 2007 Jun; 12(3):241-4. PubMed ID: 17558700
[TBL] [Abstract][Full Text] [Related]
56. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.
Ko YH; Cho EY; Kim JE; Lee SS; Huh JR; Chang HK; Yang WI; Kim CW; Kim SW; Ree HJ
Histopathology; 2004 May; 44(5):480-9. PubMed ID: 15139996
[TBL] [Abstract][Full Text] [Related]
57. Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract.
Kim SJ; Kim BS; Choi CW; Seo HY; Seol HR; Sung HJ; Kim IS; Kim CY; Jung KY; Kim JS
Leuk Lymphoma; 2006 Jul; 47(7):1265-73. PubMed ID: 16923556
[TBL] [Abstract][Full Text] [Related]
58. Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy.
Kim K; Chie EK; Kim CW; Kim IH; Park CI
Jpn J Clin Oncol; 2005 Jan; 35(1):1-5. PubMed ID: 15681596
[TBL] [Abstract][Full Text] [Related]
59. Aggressive sino-nasal non-Hodgkin's lymphoma diagnosed in Nottinghamshire, UK, between 1987 and 1996.
Quraishi MS; Bessell EM; Clark DM; Jones NS; Bradley PJ
Clin Oncol (R Coll Radiol); 2001; 13(4):269-72. PubMed ID: 11554623
[TBL] [Abstract][Full Text] [Related]
60. Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases.
Takahashi E; Asano N; Li C; Tanaka T; Shimada K; Shimada S; Yoshino T; Kojima M; Hara K; Eimoto T; Nakamura S
Histopathology; 2008 Apr; 52(5):585-96. PubMed ID: 18370955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]